- Home
- LSTA vs MDRR Comparison
LSTA vs MDRR Comparison
Compare LSTA & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- MDRR
- Stock Information
- Founded
- LSTA 1980
- MDRR 2015
- Country
- LSTA United States
- MDRR United States
- Employees
- LSTA N/A
- MDRR N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- MDRR Real Estate Investment Trusts
- Sector
- LSTA Health Care
- MDRR Real Estate
- Exchange
- LSTA Nasdaq
- MDRR Nasdaq
- Market Cap
- LSTA 20.9M
- MDRR 17.1M
- IPO Year
- LSTA N/A
- MDRR 2018
- Fundamental
- Price
- LSTA $2.52
- MDRR $13.53
- Analyst Decision
- LSTA Strong Buy
- MDRR
- Analyst Count
- LSTA 2
- MDRR 0
- Target Price
- LSTA $23.50
- MDRR N/A
- AVG Volume (30 Days)
- LSTA 23.5K
- MDRR 1.8K
- Earning Date
- LSTA 11-11-2025
- MDRR 11-11-2025
- Dividend Yield
- LSTA N/A
- MDRR 2.05%
- EPS Growth
- LSTA N/A
- MDRR N/A
- EPS
- LSTA N/A
- MDRR N/A
- Revenue
- LSTA $1,070,000.00
- MDRR $9,649,145.00
- Revenue This Year
- LSTA N/A
- MDRR N/A
- Revenue Next Year
- LSTA N/A
- MDRR N/A
- P/E Ratio
- LSTA N/A
- MDRR N/A
- Revenue Growth
- LSTA N/A
- MDRR N/A
- 52 Week Low
- LSTA $1.87
- MDRR $9.55
- 52 Week High
- LSTA $4.20
- MDRR $15.00
- Technical
- Relative Strength Index (RSI)
- LSTA 54.15
- MDRR 54.06
- Support Level
- LSTA $2.36
- MDRR $13.13
- Resistance Level
- LSTA $2.62
- MDRR $14.00
- Average True Range (ATR)
- LSTA 0.18
- MDRR 0.12
- MACD
- LSTA 0.03
- MDRR -0.10
- Stochastic Oscillator
- LSTA 72.08
- MDRR 44.41
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.